The overarching goal of this revised NRSA application is to provide a high quality mentored training experience for those future clinical cardiovascular researchers who have the potential to become the thought leaders of the next generation. The proposed training program will allow us to attract the best post-doctoral fellows into clinical research and ensure a high rate of retention of these fellows in academics after completion of training. By achieving the goal of the program, we will address the national priority of developing academic clinical researchers who can fill vital roles along the gamut of research priorities from bench to bedside, and include translational researchers as well as clinical trialists and outcomes researchers. The three objectives of this NRSA training program in clinical cardiovascular research are to provide trainees with: 1) didactic training in the methods of clinical research, 2) a mentored research experience, and 3) training and experience in """"""""survival skills"""""""" required for a successful academic career. Trainees will spend at least 2 years in this program and devote 100% effort to the program while they are in it. We are requesting 6 trainee slots at the post-doctoral level. Formal training of participating mentors on the essentials of good mentoring will be a major feature of our program. Interdisciplinary co-mentoring will be encouraged. Twenty-one faculty representing 5 Departments at Duke (Medicine, Surgery, Anesthesiology, Pediatrics, Behavioral Medicine/Psychiatry) will participate as mentors in this program. They are organized into three general research tracks: translational (patient-oriented), clinical trials, and outcomes. These three tracks will be distinguished by the program of didactic course work chosen and the customized mentored research program created for each trainee. During the course of each fellowship, several methods will be used to monitor progress, including quarterly meetings for each fellow with the Program Director. Outcomes expected from each fellow accepted into this NRSA program that will be used to assess progress will include presentations at Duke research conferences and at national meetings, peer-reviewed publications, and at least one grant application to support the trainee's post-fellowship research. Particular emphasis will be given by the Program Director and faculty to assisting each fellow to obtain a post-fellowship faculty position in academics that will allow continuation of their research work. Program graduates will also be monitored with annual contacts to ensure continued success and establishment of a stable academic career. The proposed NRSA program will organize the abundant resources available at Duke for clinical research into a focused and efficient program for training the clinical cardiovascular thought leaders of the future.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
1T32HL069749-01A1
Application #
6593152
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F3))
Program Officer
Schucker, Beth
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$195,692
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Fanaroff, Alexander C; Zakroysky, Pearl; Wojdyla, Daniel et al. (2018) Relationship Between Operator Volume and Long-Term Outcomes after Percutaneous Coronary Intervention: A Report from the NCDR CathPCI Registry. Circulation :
Friedman, Daniel J; Fudim, Marat; Overton, Robert et al. (2018) The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients. Am Heart J 201:17-24
Vaduganathan, Muthiah; Cheema, Baljash; Cleveland, Erin et al. (2018) Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial. Eur J Heart Fail 20:677-686
Cheema, Baljash; Ambrosy, Andrew P; Kaplan, Rachel M et al. (2018) Lessons learned in acute heart failure. Eur J Heart Fail 20:630-641
Greene, Stephen J; Butler, Javed; Fonarow, Gregg C et al. (2018) Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail 20:281-291
Friedman, Daniel J; Parzynski, Craig S; Heist, E Kevin et al. (2018) Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry. Circulation 137:2463-2477
Vaduganathan, Muthiah; Samman Tahhan, Ayman; Greene, Stephen J et al. (2018) Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years. Eur J Heart Fail 20:1068-1071
Fudim, Marat; O'Connor, Christopher M; Dunning, Allison et al. (2018) Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail 20:304-314
Alenezi, Fawaz; Mandawat, Aditya; Il'Giovine, Zachary J et al. (2018) Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary Hypertension. Circ Cardiovasc Imaging 11:e006984
Friedman, Daniel J; Al-Khatib, Sana M (2018) Response by Friedman and Al-Khatib to Letter Regarding Article, ""Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry"". Circulation 138:2972-2973

Showing the most recent 10 out of 186 publications